Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase pseudogene" (ENSG00000274601) is a pseudogene that shares sequence homology with the protein-coding gene MGAT2, which encodes an enzyme involved in N-glycan biosynthesis. Unlike MGAT2, the pseudogene does not encode a functional protein and is incapable of catalyzing glycosyltransferase reactions. Pseudogenes can play regulatory roles via noncoding RNA transcripts, potentially affecting their parent gene expression through mechanisms like competing endogenous RNA (ceRNA) networks or as sources of small interfering RNAs. However, such functions are context-dependent and not well characterized for each individual pseudogene[2][4][6][8]. In summary: ENSG00000274601 is a **pseudogene**—not a canonical therapeutic target (enzyme, receptor, etc.), and thus, it should not be considered a target for drug discovery or direct pharmacological modulation. It may have *regulatory RNA roles*, but these are not typically targeted in current drug development[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase pseudogene.